Article citationsMore>>
Connolly, S.J., Ezekowitz, M.D., Yusuf, S., Eikelboom, J., Oldgren, J., Parekh, A., Pogue, J., Reilly, P.A., Themeles, E., Varrone, J., Wang, S., Alings, M., Xavier, D., Zhu, J., Diaz, R., Lewis, B.S., Darius, H., Diener, H.C., Joyner, C.D. and Wallentin, L. (2009) Dabigatran versus Warfarin in Patients with Atrial Fibrillation. New England Journal of Medicine, 361, 1139-1151.
http://dx.doi.org/10.1056/NEJMoa0905561
has been cited by the following article:
-
TITLE:
Elderly Disabled Patients in Oral Anticoagulation Treatment: An Evaluation of a Bioanalyst-Led Management Program Reaching an Average of 72% of Time in Therapeutic Range
AUTHORS:
Thomas Vedtofte, Gitte Vedel Melsen, Lise Bathum, Christina Ellervik, Maja Jørgensen
KEYWORDS:
Warfarin, INR, Time in Therapeutic Range, Elderly, Nursery Care Setting
JOURNAL NAME:
World Journal of Cardiovascular Diseases,
Vol.4 No.12,
November
28,
2014
ABSTRACT: Introduction: The need for anticoagulation therapy increases with age, mainly due to the increased prevalence of atrial fibrillation. Time in therapeutic range (TTR) is a marker of the quality of the therapy as TTR is inversely correlated with adverse reactions. We developed a bioanalyst-led management program for control of warfarin treatment in elderly disabled patients in their own home and maintain a high TTR. Material and Methods: Residents in nursing home settings were included. Visiting nurses measured INR with a point of care testing device. If INR was within Therapeutic Range (TR), the nurse dosed warfarin unaltered. If INR was out of TR, the visiting nurse contacted a specially trained bioanalyst by phone. An explanation was sought, and a new dosage plan was made. Results: A total of 579 patients were included; 356 females (61%). Mean age was 79.6 years. Approximately 10% were residents in nursing home settings and the rest in domiciliary care. TTR was 72%. The subtherapeutic values were 15% and supratherapeutic values 13%. In total, 139 patients died during the study period. Ten deaths could be related to possible side effects of warfarin treatment. Conclusions: Our results indicate that a bioanalyst-led program is able to simplify anticoagulation monitoring, while maintaining INR control similar to a specialized clinic. Furthermore, we avoided hospitalizations when INR was unacceptably high by treating the patient with oral vitamin-K at home. Our findings could be helpful when planning warfarin treatment in elderly, fragile patients.
Related Articles:
-
Casimir Komenan
-
Jai Dev Chandel, Nand Lal Singh
-
Zheng Yuan
-
Samuel Rhodes, Xiaochen Wang, Wenlang Liang, Hyoung Jin Cho, Jiyu Fang
-
Sydney N. Jackson, Rongson Pongdee